PHAS logo

PHAS Equity Ratio

Current (TTM)-153.67%
PHAS Equity Ratio (-2117.61% → -153.67%)
High-resolution chart · PNG

PHAS equity ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Equity Ratio — Annual fiscal periods
Period endingEquity Ratio
-153.6736%
-50.0467%
72.7059%
80.8032%
-690.9426%
-2,117.6099%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.